MED Stock Summary and Trading Ideas (Medifast | NYSE:MED)

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Medifast trades on the NYSE stock market under the symbol MED.

As of December 23, 2025, MED stock price declined to $11.25 with 28,978 million shares trading.

MED has a beta of 0.91, meaning it tends to be less sensitive to market movements. MED has a correlation of 0.13 to the broad based SPY ETF.

MED has a market cap of $123.65 million. This is considered a Micro Cap stock.

Last quarter Medifast reported $89 million in Revenue and -$.21 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.01.

In the last 3 years, MED traded as high as $131.42 and as low as $10.36.

The top ETF exchange traded funds that MED belongs to (by Net Assets): FNDA, VTI, IWM, AVUV, VDC.

MED has underperformed the market in the last year with a price return of -33.5% while the SPY ETF gained +17.4%. MED has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -21.4% and -1.0%, respectively, while the SPY returned +3.2% and +0.7%, respectively.

MED support price is $11.06 and resistance is $11.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MED shares will trade within this expected range on the day.